首页 › 癌症（所有类型） › 得克萨斯州 › San Antonio
San Antonio TX 癌症（所有类型）临床试验
41项针对 癌症（所有类型）的研究正在 San Antonio及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of ASP3082 in Adults With Advanced Solid Tumors
招募中1 期
- NEXT Oncology, San Antonio
A Study of PHN-012 in Patients With Advanced Solid Tumors
招募中1 期
- PHN-012-001 Site, San Antonio
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
招募中1 期
- South Texas Accelerated Research Therapeutics (START), San Antonio
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
招募中2 期
- Mays Cancer Center ( Site 0039), San Antonio
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
招募中1 期
- NEXT Oncology, San Antonio
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
招募中1 期
- GSK Investigational Site, San Antonio
Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
招募中1 期
- NEXT Oncology ( Site 0151), San Antonio
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
招募中3 期
- START San Antonio ( Site 0104), San Antonio
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- NEXT Oncology San Antonio, San Antonio
- START Texas, San Antonio
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
招募中2/3 期
- Sam Clinical Research Center, San Antonio
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
招募中1/2 期
- The Cancer Therapy and Research Center at UTHSCSA, San Antonio
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
招募中1 期
- NEXT Oncology, San Antonio
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
招募中3 期
- Texas Oncology-San Antonio Cancer Care, San Antonio
- Texas Oncology - San Antonio Northeast, San Antonio
- Texas Oncology - San Antonio Stone Oak, San Antonio
Prostate Active Surveillance Study
招募中观察性研究
- University of Texas Health Science Center, San Antonio, San Antonio
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
招募中1 期
- NEXT Oncology, San Antonio
Project: Every Child for Younger Patients With Cancer
招募中观察性研究
- Children's Hospital of San Antonio, San Antonio
- Methodist Children's Hospital of South Texas, San Antonio
- University of Texas Health Science Center at San Antonio, San Antonio
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
招募中1/2 期
- Site 01, San Antonio
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
招募中1 期
- NEXT Oncology San Antonio, San Antonio
- START- San Antonio, San Antonio
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
招募中1/2 期
- UT Health Mays Cancer Center, San Antonio
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
招募中1 期
- NEXT Oncology, San Antonio
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
招募中1 期
- START San Antonio, San Antonio
IDOV-Immune for Advanced Solid Tumors
招募中1 期
- South Texas Accelerated Research Therapeutics, San Antonio
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
招募中3 期
- Texas Oncology San Antonio Medical Center, San Antonio
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
招募中1 期
- START San Antonio, LLC., San Antonio
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
招募中1 期
- NEXT Oncology, San Antonio
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
招募中1 期
- USA Clinical Trials, San Antonio
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
招募中1/2 期
- START San Antonio, San Antonio
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
招募中1/2 期
- START, San Antonio
CT-95 in Advanced Cancers Associated With Mesothelin Expression
招募中1 期
- Context Investigational Site, San Antonio
- Context Investigational Site, San Antonio
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
招募中1 期
- Research Site #2, San Antonio
- Research Site, San Antonio
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
招募中1 期
- GSK Investigational Site, San Antonio
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
招募中1/2 期
- NEXT Oncology, San Antonio
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
招募中1 期
- NEXT San Antonio, San Antonio
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
招募中1 期
- NEXT Oncology San Antonio, San Antonio
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
招募中1 期
- UT Health, San Antonio
A Study of YL242 in Subjects With Advanced Solid Tumors
招募中1/2 期
- US-207, San Antonio
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
招募中1 期
- NEXT Oncology, San Antonio
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
招募中1 期
- South Texas Accelerated Research Therapeutics, LLC, San Antonio
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
招募中1/2 期
- NEXT Oncology, San Antonio
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
招募中
- University of Texas Health Science Center at San Antonio, San Antonio
其他城市的 癌症（所有类型）试验
- Houston, TX121 项研究
- New York City, NY109 项研究
- Boston, MA85 项研究
- Los Angeles, CA74 项研究
- Nashville, TN65 项研究
- Philadelphia, PA59 项研究
- Washington, DC58 项研究
- Durham, NC58 项研究
- Chicago, IL51 项研究
- Atlanta, GA49 项研究
- Seattle, WA49 项研究
- Arlington, VA48 项研究
San Antonio的其他研究
- 非小细胞肺癌59 项研究
- 乳腺癌47 项研究
- 结直肠癌46 项研究
- 转移性癌症44 项研究
- 肥胖症40 项研究
- 2型糖尿病37 项研究
- 超重34 项研究
- 卵巢癌31 项研究
- 胰腺癌31 项研究
- 前列腺癌28 项研究
- 子宫内膜癌27 项研究
- 肺癌26 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。